Although derivatization and enzymatic resolution techniques are useful, these methodologies are often specific to a certain compound class and therefore less relevant in identifying an appropriate solution. Resolution of enantiomers through crystallization is often a preferred option, favored over costly preparative chromatography during process development and manufacturing.
AMRI has the experience to solve your most complex resolution problems through crystallization, and we prioritize non-proprietary solutions to reduce costs and address intellectual property issues.
We also provide a complete suite of bioanalytical, biocatalysis and bioprocess services to address your drug discovery and development objectives.